Recombinant human hepatitis B vaccine initiating alopecia areata: testing the hypothesis using the C3H/HeJ mouse model
Untoward effects of human vaccines suggest that recombinant hepatitis B vaccine may induce alopecia areata (AA) in some patients. Similar untoward immunological effects may also account for AA-like diseases in domestic species. In this study, the C3H/HeJ spontaneous adult onset AA mouse model was us...
Saved in:
Published in | Veterinary dermatology Vol. 20; no. 2; pp. 99 - 104 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Oxford, UK : Blackwell Publishing Ltd
01.04.2009
Blackwell Publishing Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Untoward effects of human vaccines suggest that recombinant hepatitis B vaccine may induce alopecia areata (AA) in some patients. Similar untoward immunological effects may also account for AA-like diseases in domestic species. In this study, the C3H/HeJ spontaneous adult onset AA mouse model was used to test the role, if any, of recombinant hepatitis B vaccine on the initiation or activation of AA. Initial experiments demonstrated no effect on induction of AA in young adult female C3H/HeJ mice (P = 0.5689). By contrast, older females, those at the age when AA first begins to appear in this strain, had a significant increase (P = 0.0264) in the time of onset of AA, suggesting that the vaccine may initiate disease in mice predisposed to AA. However, larger vaccine trials, which included diphtheria and tetanus toxoids as additional controls, did not support these initial result findings and suggest that AA associated with vaccination may be within the normal background levels of the given population. |
---|---|
Bibliography: | http://dx.doi.org/10.1111/j.1365-3164.2008.00692.x ark:/67375/WNG-PRDLX38J-5 ArticleID:VDE692 istex:2D3B9BCC640EB146782AA6497DB727B7A4F71E0E No conflict of interest has been declared. Sources of funding This work was supported by a subcontract from the Centers for Disease Control (200‐2002‐00732). Core facilities at The Jackson Laboratory were supported by the National Cancer Institute (CA34196). The alopecia areata mouse model development was supported by the National Alopecia Areata Foundation (NAAF). Conflict of interest ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0959-4493 1365-3164 |
DOI: | 10.1111/j.1365-3164.2008.00692.x |